|
[1]
|
Bronowicki, J.P., Vetter, D., Dumas, F., et al. (1994) Transcatheter Oily Chemoembolization for Hepatocellular Carcinoma. A 4-Year Study of 127 French Patients. Cancer, 74, 16-24.
http://dx.doi.org/10.1002/1097-0142(19940701)74:1<16::AID-CNCR2820740105>3.0.CO;2-V
|
|
|
[2]
|
Vetter, D., Wenger, J.J., Bergier, J.M., et al. (1991) Transcatheter Oily Chemoembolization in the Management of Advanced Hepatocellular Carcinoma in Cirrhosis: Results of a Western Comparative Study in 60 Patients. Hepatology, 13, 427-433.
http://dx.doi.org/10.1002/hep.1840130308
|
|
|
[3]
|
Mondazzi, L., Bottelli, R., Brambilla, G., et al. (1994) Transcatheter Oily Chemoembolization for the Treatment of Hepatocellular Carcinoma: A Multivariate Analysis of Prognostic Factors. Hepatology, 19, 1115-1123.
http://dx.doi.org/10.1002/hep.1840190508
|
|
|
[4]
|
Lo, C.M., Ngan, H., Tso, W.K., et al. (2002) Randomized Controlled Trial of Transarterial Lipiodol Chemoembolization for Unresectable Hepatocellular Carcinoma. Hepatology, 35, 1164-1171.
http://dx.doi.org/10.1053/jhep.2002.33156
|
|
|
[5]
|
Llovet, J.M., Real, M.I., Montaňa, X., et al. (2002) Arterial Embolisation or Chemoembolisation versus Symptomatic Treatment in Patients with Unresectable Hepatocellular Carcinoma: A Randomised Controlled Trial. The Lancet, 359, 1734-1739.
http://dx.doi.org/10.1016/S0140-6736(02)08649-X
|
|
|
[6]
|
Llovet, J.M. and Bruix, J. (2003) Systematic Review of Randomized Trials for Unresectable Hepatocellular Carcinoma: Chemoembolization Improves Survival. Hepatology, 37, 429-442.
http://dx.doi.org/10.1053/jhep.2003.50047
|
|
|
[7]
|
Bismuth, H., Morino, M., Sherlock, D., et al. (1992) Primary Treatment of Hepatocellular Carcinoma by Arterial Chemoembolization. The American Journal of Surgery, 163, 387-394.
http://dx.doi.org/10.1016/0002-9610(92)90039-T
|
|
|
[8]
|
Yamada, R., Kishi, K., Sonomura, T., et al. (1990) Transcatheter Arterial Embolization in Unresectable Hepatocellular Carcinoma. CardioVascular and Interventional Radiology, 13, 135-139.
http://dx.doi.org/10.1007/BF02575464
|
|
|
[9]
|
Stuart, K., Stokes, K., Jenkins, R., et al. (1993) Treatment of Hepatocellular Carcinoma Using Doxorubicin/Ethiodized Oil/Gelatin Powder Chemoembolization. Cancer, 72, 3202-3209.
http://dx.doi.org/10.1002/1097-0142(19931201)72:11<3202::AID-CNCR2820721112>3.0.CO;2-4
|
|
|
[10]
|
Bruix, J. and Sherman, R. (2005) Management of Hepatocellular Carcinoma. Hepatology, 42, 1208-1236.
http://dx.doi.org/10.1002/hep.20933
|
|
|
[11]
|
Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., et al. (1973) Transection of the Oesophagus for Bleeding Oesophageal Varices. British Journal of Surgery, 60, 646-649.
http://dx.doi.org/10.1002/bjs.1800600817
|
|
|
[12]
|
Kamath, P.S., Wiesner, R.H., Malinchoc, M., et al. (2001) A Model to Predict Survival in Patients with End-Stage Liver Disease. Hepatology, 33, 464-470.
http://dx.doi.org/10.1053/jhep.2001.22172
|
|
|
[13]
|
Vauthey, J.N., Lauwers, G.Y., Esnaola, N.F., et al. (2002) Simplified Staging for Hepatocellular Carcinoma. Journal of Clinical Oncology, 20, 1527-1536.
http://dx.doi.org/10.1200/JCO.20.6.1527
|
|
|
[14]
|
Calle, E.E., Rodriguez, C., Walker-Thurmond, K., et al. (2003) Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults. The New England Journal of Medicine, 348, 1625-1638.
http://dx.doi.org/10.1056/NEJMoa021423
|
|
|
[15]
|
Ohki, T., Tateishi, R., Sato, T., et al. (2008) Obesity Is an Independent Risk Factor for Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients. Clinical Gastroenterology and Hepatology, 6, 459-464.
http://dx.doi.org/10.1016/j.cgh.2008.02.012
|
|
|
[16]
|
Saito, M., Seo, Y., Yano, Y., et al. (2013) Reduction in Non-Protein Respiratory Quotient Is Related to Overall Survival after Hepatocellular Carcinoma Treatment. PLoS ONE, 8, e55441.
http://dx.doi.org/10.1371/journal.pone.0055441
|
|
|
[17]
|
Mathur, A., Hernandez, J., Shaheen, F., et al. (2011) Preoperative Computed Tomography Measurements of Pancreatic Steatosis and Visceral Fat: Prognostic Markers for Dissemination and Lethality of Pancreatic Adenocarcinoma. HPB (Oxford), 13, 404-410.
http://dx.doi.org/10.1111/j.1477-2574.2011.00304.x
|
|
|
[18]
|
House, M.G., Fong, Y., Arnaoutakis, D.J., et al. (2008) Preoperative Predictors for Complications after Pancreaticoduodenectomy: Impact of BMI and Body Fat Distribution. Journal of Gastrointestinal Surgery, 12, 270-278.
http://dx.doi.org/10.1007/s11605-007-0421-7
|
|
|
[19]
|
Kudo, M. and Okanoue, T. (2007) Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Manual Proposed by the Japan Society of Hepatology. Oncology, 72, 2-15.
http://dx.doi.org/10.1159/000111702
|
|
|
[20]
|
Mitsiopoulos, N., Baumgartner, R.N., Heymsfield, S.B., et al. (1998) Cadaver Validation of Skeletal Muscle Measurement by Magnetic Resonance Imaging and Computerized Tomography. Journal of Applied Physiology, 85, 115-122.
|
|
|
[21]
|
Kvist, H., Sjostrom, L. and Tylén, U. (1986) Adipose Tissue Volume Determinations in Women by Computed Tomography: Technical Considerations. International Journal of Obesity, 10, 53-67.
|
|
|
[22]
|
Vehmas, T., Kairemo, K.J. and Taavitsainen, M.J. (1996) Measuring Visceral Adipose Tissue Content from Contrast Enhanced Computed Tomography. International Journal of Obesity and Related Metabolic Disorders, 20, 570-573.
|
|
|
[23]
|
Mourtzakis, M., Prado, C.M., Lieffers, J.R., et al. (2008) A Practical and Precise Approach to Quantification of Body Composition in Cancer Patients Using Computed Tomography Images Acquired during Routine Care. Applied Physiology, Nutrition, and Metabolism, 33, 997-1006.
http://dx.doi.org/10.1139/H08-075
|
|
|
[24]
|
Prado, C.M., Lieffers, J.R., McCargar, L.J., et al. (2008) Prevalence and Clinical Implications of Sarcopenic Obesity in Patients with Solid Tumours of the Respiratory and Gastrointestinal Tracts: A Population-Based Study. The Lancet Oncology, 9, 629-635.
http://dx.doi.org/10.1016/S1470-2045(08)70153-0
|
|
|
[25]
|
Montano-Loza, A.J., Meza-Junco, J., Prado, C.M., et al. (2012) Muscle Wasting Is Associated with Mortality in Patients with Cirrhosis. Clinical Gastroenterology and Hepatology, 10, 166-173.
http://dx.doi.org/10.1016/j.cgh.2011.08.028
|
|
|
[26]
|
Kashihara, H., Lee, J.S., Kawakubo, K., et al. (2009) Criteria of Waist Circumference According to Computed Tomography-Measured Visceral Fat Area and the Clustering of Cardiovascular Risk Factors. Circulation Journal, 73, 1881-1886.
http://dx.doi.org/10.1253/circj.CJ-09-0183
|
|
|
[27]
|
Starley, B.Q., Calcagno, C.J. and Harrison, S.A. (2010) Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection. Hepatology, 51, 1820-1832.
http://dx.doi.org/10.1002/hep.23594
|
|
|
[28]
|
Kopelman, P.G. (2000) Obesity as a Medical Problem. Nature, 404, 635-643.
|
|
|
[29]
|
Regimbeau, J.M., Colombat, M., Mognol, P., et al. (2004) Obesity and Diabetes as a Risk Factor for Hepatocellular Carcinoma. Liver Transplantation, 10, S69-S73.
http://dx.doi.org/10.1002/lt.20033
|
|
|
[30]
|
Gonzalez, L., Blanc, J.F., Sa Cunha, A., et al. (2004) Obesity as a Risk Factor for Hepatocellular Carcinoma in a Noncirrhotic Patient. Seminars in Liver Disease, 24, 415-419.
http://dx.doi.org/10.1055/s-2004-860870
|
|
|
[31]
|
Nair, S., Mason, A., Eason, J., et al. (2002) Is Obesity an Independent Risk Factor for Hepatocellular Carcinoma in Cirrhosis? Hepatology, 36, 150-155.
http://dx.doi.org/10.1053/jhep.2002.33713
|
|
|
[32]
|
Fox, C.S., Massaro, J.M., Hoffmann, U., et al. (2007) Abdominal Visceral and Subcutaneous Adipose Tissue Compartments: Association with Metabolic Risk Factors in the Framingham Heart Study. Circulation, 116, 39-48.
http://dx.doi.org/10.1161/CIRCULATIONAHA.106.675355
|
|
|
[33]
|
Oka, R., Kobayashi, J., Yagi, K., et al. (2008) Reassessment of the Cutoff Values of Waist Circumference and Visceral Fat Area for Identifying Japanese Subjects at Risk for the Metabolic Syndrome. Diabetes Research and Clinical Practice, 79, 474-481.
http://dx.doi.org/10.1016/j.diabres.2007.10.016
|
|
|
[34]
|
Hayashi, T., Boyko, E.J., McNeely, M.J., et al. (2007) Minimum Waist and Visceral Fat Values for Identifying Japanese Americans at Risk for the Metabolic Syndrome. Diabetes Care, 30, 120-127.
http://dx.doi.org/10.2337/dc06-0739
|
|
|
[35]
|
Eguchi, Y., Mizuta, T., Ishibashi, E., et al. (2009) Hepatitis C Virus Infection Enhances Insulin Resistance Induced by Visceral Fat Accumulation. Liver International, 29, 213-220.
http://dx.doi.org/10.1111/j.1478-3231.2008.01853.x
|
|
|
[36]
|
González-Reimers, E., Castellano-Higuera, A., Alemán-Valls, R., et al. (2009) Relation between Body Fat and Liver Fat Accumulation and Cytokine Pattern in Non-Alcoholic Patients with Chronic HCV Infection. Annals of Nutrition and Metabolism, 55, 351-357.
http://dx.doi.org/10.1159/000252351
|
|
|
[37]
|
Ahima, R.S. (2006) Adipose Tissue as an Endocrine Organ. Obesity, 14, 242S-249S.
http://dx.doi.org/10.1038/oby.2006.317
|
|
|
[38]
|
Vongsuvanh, R., George, J., Qiao, L., et al. (2013) Visceral Adiposity in Gastrointestinal and Hepatic Carcinogenesis. Cancer Letters, 330, 1-10.
http://dx.doi.org/10.1016/j.canlet.2012.11.038
|
|
|
[39]
|
Arano, T., Nakagawa, H., Tateishi, R., et al. (2011) Serum Level of Adiponectin and the Risk of Liver Cancer Development in Chronic Hepatitis C Patients. International Journal of Cancer, 129, 2226-2235.
http://dx.doi.org/10.1002/ijc.25861
|
|
|
[40]
|
Alexia, C., Fallot, G., Lasfer, M., et al. (2004) An Evaluation of the Role of Insulin-Like Growth Factors (IGF) and of Type-I IGF Receptor Signalling in Hepatocarcinogenesis and in the Resistance of Hepatocarcinoma Cells against Drug-Induced Apoptosis. Biochemical Pharmacology, 68, 1003-1015.
http://dx.doi.org/10.1016/j.bcp.2004.05.029
|
|
|
[41]
|
Giovannucci, E. and Michaud, D. (2007) The Role of Obesity and Related Metabolic Disturbances in Cancers of the Colon, Prostate, and Pancreas. Gastroenterology, 132, 2208-2225.
http://dx.doi.org/10.1053/j.gastro.2007.03.050
|
|
|
[42]
|
Kaido, T., Ogawa, K., Fujimoto, Y., et al. (2013) Impact of Sarcopenia on Survival in Patients Undergoing Living Donor Liver Transplantation. American Journal of Transplantation, 13, 1549-1556.
http://dx.doi.org/10.1111/ajt.12221
|
|
|
[43]
|
Masuda, T., Shirabe, K., Ikegami, T., et al. (2014) Sarcopenia Is a Prognostic Factor in Living Donor Liver Transplantation. Liver Transplantation, 20, 401-407.
http://dx.doi.org/10.1002/lt.23811
|
|
|
[44]
|
Fearon, K.C. (2011) Cancer Cachexia and Fat-Muscle Physiology. The New England Journal of Medicine, 365, 565-567.
http://dx.doi.org/10.1056/NEJMcibr1106880
|
|
|
[45]
|
Merli, M., Lucidi, C., Giannelli, V., et al. (2010) Cirrhotic Patients Are at Risk for Health Care-Associated Bacterial Infections. Clinical Gastroenterology and Hepatology, 8, 979-985.
http://dx.doi.org/10.1016/j.cgh.2010.06.024
|
|
|
[46]
|
Wang, Y., Chen, Y., Ge, N., et al. (2012) Prognostic Significance of Alpha-Fetoprotein Status in the Outcome of Hepatocellular Carcinoma after Treatment of Transarterial Chemoembolization. Annals of Surgical Oncology, 19, 3540-3546.
http://dx.doi.org/10.1245/s10434-012-2368-5
|
|
|
[47]
|
Tein, I., Bukovac, S.W. and Xie, Z.W. (1996) Characterization of the Human Plasmalemmal Carnitine Transporter in Cultured Skin Fibroblasts. Archives of Biochemistry and Biophysics, 329, 145-155.
http://dx.doi.org/10.1006/abbi.1996.0203
|
|
|
[48]
|
Yokogawa, K., Yonekawa, M., Tamai, I., et al. (1999) Loss of Wild-Type Carrier-Mediated L-Carnitine Transport Activity in Hepatocytes of Juvenile Visceral Steatosis Mice. Hepatology, 30, 997-1001.
http://dx.doi.org/10.1002/hep.510300423
|
|
|
[49]
|
Kim, Y.J., Kim, K.Y., Kim, M.S., et al. (2008) A Mixture of the Aqueous Extract of Garcinia cambogia, Soy Peptide and L: -Carnitine Reduces the Accumulation of Visceral Fat Mass in Rats Rendered Obese by a High Fat Diet. Genes & Nutrition, 2, 353-358.
http://dx.doi.org/10.1007/s12263-007-0070-1
|
|